Evidence map›Paper›PMID 41753723›Full record

ReviewMicroorganisms2026

Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies.

Ikram Joubair, Abdellatif Errabbani, Soukaina Daif, Jesus Zueco, Salim Bounou, Ouafaa Fassi Fihri, Ismaïl Moukadiri

Abstract readReview
In one paragraph

Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ikram JoubairEngineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes (RN6, Rond-Point Bensouda), Fez 30070, Morocco.ORCID 0009-0000-0151-4888
Abdellatif ErrabbaniEngineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes (RN6, Rond-Point Bensouda), Fez 30070, Morocco.ORCID 0000-0002-5632-5117
Soukaina DaifPathology and Veterinary Public Health Department, Institut Agronomique et Vétérinaire HASSAN II, P.O. Box 6202, Rabat 10000, Morocco.
Jesus ZuecoUnidad de Microbiología, Facultad de Farmacia, Universidad de Valencia, Avda. Vicente Andrés Estelles s/n, Burjassot, 46100 Valencia, Spain.
Salim BounouEngineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes (RN6, Rond-Point Bensouda), Fez 30070, Morocco.
Ouafaa Fassi FihriPathology and Veterinary Public Health Department, Institut Agronomique et Vétérinaire HASSAN II, P.O. Box 6202, Rabat 10000, Morocco.ORCID 0000-0001-8056-7979
Ismaïl MoukadiriEngineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes (RN6, Rond-Point Bensouda), Fez 30070, Morocco.ORCID 0000-0002-6557-4430

Funding

MESRSI and FOCP via ARPD AnVacProd
6 · The paper itself

Abstract

Bluetongue (BT) is a noncontagious, arthropod-borne viral disease of domestic and wild ruminants caused by bluetongue virus (BTV), an arbovirus of the

Indexed as

bluetongue virus (BTV)DIVAepidemiologyMediterranean basinnext generation vaccineserotypesvaccinationvirus outbreaks

Identifiers

PMID41753723
PMCPMC12942964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.